Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
GLP-1 receptor agonists are licensed to treat diabetes and obesity, but data on whether these medications alleviate or exacerbate anxiety, depression, and self-harm are mixed
GLP-1 receptor agonists have therefore emerged as a promising adjunct in the HS treatment landscape, given their established metabolic benefits and emerging evidence suggesting anti-inflammatory effects
Monitor and report worsening or new suicidal thoughts and behaviors to your health care provider
As with any medication, GLP-1s come with their fair share of potential side effects
US$ 22.01
US$ 29.77
US$ 22.43
US$ 22.64
